Peter Pal Remenyi (Peter Remenyi, Péter Reményi)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Ejection Fraction

Disease Activity

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Jaime Sanz Caballer, Myriam Labopin, Goda Choi, Alexander Dmitrievich Kulagin, Jacopo Peccatori, Jan Vydra, Peter Pal Remenyi, Jurjen Versluis, Montserrat Rovira, Didier Blaise, Helene Labussiere-Wallet, Juan Montoro Gómez, Simona Sica, Ellen Meijer, Maija Itälä-Remes, Nicolaas Schaap, Claude-Eric Bulabois, Simona Piemontese, Mohamad Mohty, Fabio Ciceri
Younger unrelated donors may be preferable over HLA match in the PTCy era: A study from the ALWP of the EBMT. Blood (2024)
Jaime Sanz Caballer, Myriam Labopin, Goda Choi, Alexander Dmitrievich Kulagin, Jacopo Peccatori, Jan Vydra, Peter Pal Remenyi, Jurjen Versluis, Montserrat Rovira, Didier Blaise, Hélène Labussière-Wallet, Juan Montoro Gómez, Simona Sica, Ellen Meijer, Maija Itälä-Remes, Nicolaas Schaap, Claude Eric Bulabois, Simona Piemontese, Mohamad Mohty, Fabio Ciceri
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT. Blood 143 (24) (2024)
Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Pal Remenyi, Edouard Forcade, Nicolaus M Kröger, Gerard Sociè, Charles F Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Aleksandra Holowiecka, Arnon Nagler, Fabio Ciceri, Florent Malard
Improved post-transplant outcomes in recent years for AML patients with FLT3-ITD and wild-type NPM1: a report from the EBMT acute leukemia working party. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)